Impact of High Glucose on Ocular Surface Glycocalyx Components: Implications for Diabetes-Associated Ocular Surface Damage.
Judy WengSteven TrinhRachel LeeRana MetwaleAjay SharmaPublished in: International journal of molecular sciences (2022)
Diabetes mellitus causes several detrimental effects on the ocular surface, including compromised barrier function and an increased risk of infections. The glycocalyx plays a vital role in barrier function. The present study was designed to test the effect of a high glucose level on components of glycocalyx. Stratified human corneal and conjunctival epithelial cells were exposed to a high glucose concentration for 24 and 72 h. Changes in Mucin (MUC) 1, 4, 16 expression were quantified using real-time PCR and ELISA. Rose bengal and jacalin staining were used to assess the spatial distribution of MUC16 and O-glycosylation. Changes in the gene expression of five glycosyltransferases and forty-two proteins involved in cell proliferation and the cell cycle were also quantified using PCR and a gene array. High glucose exposure did not affect the level or spatial distribution of membrane-tethered MUC 1, 4, and 16 either in the corneal or conjunctival epithelial cells. No change in gene expression in glycosyltransferases was observed, but a decrease in the gene expression of proteins involved in cell proliferation and the cell cycle was observed. A high-glucose-mediated decrease in gene expression of proteins involved in cellular proliferation of corneal and conjunctival epithelial cells may be one of the mechanisms underlying a diabetes-associated decrease in ocular surface's glycocalyx.
Keyphrases
- high glucose
- cell cycle
- gene expression
- endothelial cells
- cell proliferation
- dna methylation
- real time pcr
- type diabetes
- cardiovascular disease
- glycemic control
- optical coherence tomography
- wound healing
- genome wide
- oxidative stress
- poor prognosis
- signaling pathway
- pi k akt
- high resolution
- copy number
- high throughput
- insulin resistance
- cataract surgery
- single cell
- induced pluripotent stem cells
- long non coding rna
- monoclonal antibody